Results 301 to 310 of about 36,666 (331)
Some of the next articles are maybe not open access.

Endothelin

Hormone Research, 1990
Endothelin (ET) belongs to a family of 21 amino acid peptides comprising at least three isoforms in man. Originally identified as an endothelium-derived vasoconstrictive substance, ET arises from a precursor peptide which is cleaved and released by a specific ET-converting enzyme.
P E, Chabrier, P, Braquet
openaire   +2 more sources

The endothelin system and endothelin receptor antagonists

Current Opinion in Nephrology & Hypertension, 2012
There is increasing evidence that endothelin receptor blockade and, in particular, ET(A) receptor blockade not only confers protection against proteinuric renal disease in diabetes but also confers vasculoprotection.Recent clinical trials using ET(A) receptor blockade in treating proteinuria and chronic kidney disease as well as atherosclerosis show ...
Anna M.D. Watson, Karin Jandeleit-Dahm
openaire   +3 more sources

Endothelin, endothelin receptors, and endothelin antagonists

Current Opinion in Nephrology and Hypertension, 1994
Endothelin is a peptide with potent biologic effects in vascular and nonvascular cells. Its effects are mediated by two receptors, ETA and ETB, and possibly also by a third receptor, ETC. In vascular smooth muscle cells, endothelin causes profound contraction and also has proliferative effects, mainly through activation of ETA but also through ETB ...
openaire   +3 more sources

Endothelins Are Angiogenic

Journal of Cardiovascular Pharmacology, 2000
Endothelins-1 and 3 (ET-1 and 3) were evaluated for angiogenesis in the rat cornea. Bisected 2 mm pellets containing 20-1000 ng of ET-1 or ET-3 in Hydron were placed in corneal micro-pockets. Murine vascular endothelial growth factor (VEGF) and human interleukin-8 (IL-8) were positive controls.
Eugene L. Bek, Marvin A. McMillen
openaire   +3 more sources

Endothelin

2006
In humans, the endothelins (ETs) comprise a family of three 21-amino-acid peptides, ET-1, ET-2 and ET-3. ET-1 is synthesised from a biologically inactive precursor, Big ET-1, by an unusual hydrolysis of the Trp21 -Val22 bond by the endothelin converting enzyme (ECE-1).
A P, Davenport, J J, Maguire
openaire   +2 more sources

Biotinylated endothelin as a probe for the endothelin receptor

Peptides, 1991
Biotinylated derivatives of endothelin (ET)-1 were prepared by chemical modification of ET-1 with sulfosuccinimidyl 6-(biotinamido) hexanoate. Two major biotinylated ET analogs were purified by reversed-phase high performance liquid chromatography.
Eli Hazum   +4 more
openaire   +3 more sources

Endothelins and asthma

Life Sciences, 1999
In the decade since endothelin-1 (ET-1) and related endogenous peptides were first identified as vascular endothelium-derived spasmogens, with potential pathophysiological roles in vascular diseases, there has been a significant accumulation of evidence pointing to mediator roles in obstructive respiratory diseases such as asthma.
Peter J. Henry, Roy G. Goldie
openaire   +3 more sources

Endothelins

Journal of Veterinary Medicine Series A, 1992
SummaryThe endothelins (ET) represent a novel family of at least three isopeptides (ET‐1, ET‐2, ET‐3), each consisting of 21 amino acids and two disulfide bridges. ET has originally been isolated from the supernatant of porcine aortic endothelial cells and has been found to be the most potent and long lasting vasoconstrictor agent yet discovered. ET is
openaire   +2 more sources

Endothelins and the lung

The International Journal of Biochemistry & Cell Biology, 2000
Since endothelins were discovered by Yanasigawa in 1988 it has been recognised that they may have an important role in lung pathophysiology. Despite their biological importance as vasoconstrictors the physiological role of endothelin has not yet been defined within the lungs. This review explores their role in acute and chronic disease.
Michael Boscoe   +3 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy